Sildenafil NDC 52817-340

Product information

Brand name (proprietary)

Sildenafil

Generic name (nonproprietary)

sildenafil

Active ingredients

Sildenafil citrate — 25 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

TruPharma LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 204882

Marketing start

Jun 11, 2018

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 52817-340_5b329aed-403a-bed5-e063-6394a90aa7d5SPL ID 5b329aed-403a-bed5-e063-6394a90aa7d5

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452817034030 followed by a unit qualifier and the quantity Copy

Package 52817-0340-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 204882

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.